Pink Dx

Endometrics

Endometrics develops non-invasive diagnostic tests using menstrual blood samples and genomic biomarkers to detect endometriosis for women and healthcare providers.

Mimark

The company develops protein-based diagnostic tests using gynecological fluids to identify diseases for patients, clinicians and healthcare systems.

Cispoly

This company develops methylation detection kits for the early diagnosis of gynaecological cancers for healthcare providers and public health initiatives.

AOA Dx

This biotech firm develops non-invasive liquid biopsy tests to provide healthcare providers with early-stage ovarian cancer diagnostics for their patients.

Single molecule diagnostics

This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.

Nanopath

This company develops point-of-care molecular diagnostic tests and hardware for pelvic and gynecologic infections to provide rapid results for healthcare providers and their patients.

AOA Diagnostics

This biotech company develops AI-enabled liquid biopsy blood tests to detect early-stage ovarian cancer in symptomatic women.

AOA

This company develops non-invasive liquid biopsy blood tests for the early detection of ovarian cancer for healthcare providers and patients.